By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today said that it has filed a definitive proxy statement with the US Securities and Exchange Commission and sent a letter to Illumina's shareholders urging them to tender their shares in response to its $5.7 billion takeover bid.

It also urged Illumina's shareholders to vote in favor of Roche's nominees to Illumina's board.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.